Skip to content

← All news

Markets

Travere Therapeutics stock hits 52-week high at 67.97 USD

1 source ·1 article ·Sep 3, 14:10 UTC Travere Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·Sep 3, 14:10 UTC

Travere Therapeutics stock hits 52-week high at 67.97 USD